Chi-Med to Announce 2017 Half-Year Financial Results
June 29 2017 - 5:20AM
Business Wire
Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM)
will be announcing its interim results for the six months ended
June 30, 2017 on Monday, July 31, 2017 at 7:00 am British Summer
Time (BST).
An analyst presentation will be held at 9:00 am BST (4:00 pm
Hong Kong Time) on the same day at Panmure Gordon & Co, One New
Change, London EC4M 9AF, UK, which will be webcast via the company
website at www.chi-med.com/investors/event-information/. The
presentation will be available to download before the analyst
presentation begins.
For North America based analysts and investors, Chi-Med will
also host a conference call with Q&A at 9:00 am Eastern
Daylight Time (2:00 pm BST).
Details of the analyst presentation and conference call dial-in
will be provided in the financial results announcement. A replay
will also be available on the website shortly after each event.
About Chi-Med
Chi-Med is an innovative biopharmaceutical company which
researches, develops, manufactures and sells pharmaceuticals and
healthcare products. Its Innovation Platform, Hutchison MediPharma
Limited, focuses on discovering and developing innovative
therapeutics in oncology and autoimmune diseases for the global
market. Its Commercial Platform manufactures, markets, and
distributes prescription drugs and consumer health products in
China.
Chi-Med is majority owned by the multinational conglomerate CK
Hutchison Holdings Limited (SEHK: 0001). For more information,
please visit: www.chi-med.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170629005495/en/
Chi-MedInvestor EnquiriesChristian Hogg, CEO+852 2121
8200orU.K. & International Media EnquiriesCitigate Dewe
RogersonAnthony Carlisle+44 7973 611 888
(Mobile)anthony.carlisle@cdrconsultancy.co.ukorU.S. Based Media
EnquiriesBMC CommunicationsBrad Miles+1 (917) 570 7340
(Mobile)bmiles@bmccommunications.comorSusan Duffy+1 (917) 499 8887
(Mobile)sduffy@bmccommunications.comorInvestor RelationsMatt
Beck, The Trout Group+1 (917) 415 1750
(Mobile)mbeck@troutgroup.comorDavid Dible, Citigate Dewe
Rogerson+44 7967 566 919
(Mobile)david.dible@citigatedr.co.ukorPanmure Gordon (UK)
LimitedRichard Gray / Andrew Potts+44 (20) 7886 2500
Hutchmed (china) (LSE:HCM)
Historical Stock Chart
From Apr 2024 to May 2024
Hutchmed (china) (LSE:HCM)
Historical Stock Chart
From May 2023 to May 2024